메뉴 건너뛰기




Volumn 32, Issue 4, 2006, Pages 363-370

Vaccines targeting tumour angiogenesis-a novel strategy for cancer immunotherapy

Author keywords

Angiogenesis; Endothelium; Vaccine

Indexed keywords

2 METHOXYESTRADIOL; 4 DEDIMETHYLAMINOSANCYCLINE; 5,6 DIMETHYLXANTHENONE 4 ACETIC ACID; AE 941; ANGIOGENESIS INHIBITOR; ANGIOSTATIN; ANGIOZYME; ANTINEOPLASTIC AGENT; AS 1404; BEVACIZUMAB; CANCER VACCINE; CAPTOPRIL; CGS 27023A; COMBRETASTATIN A4; DALTEPARIN; ENDOSTATIN; FUMAGILLOL CHLOROACETYLCARBAMATE; GENISTEIN; LENALIDOMIDE; MARIMASTAT; N ACETYLCOLCHINOL PHOSPHATE; N ACETYLSARCOSYLGLYCYLVALYL DEXTRO ALLOISOLEUCYLTHREONYLNORVALYLISOLEUCYLARGINYLPROLINE ETHYLAMIDE; PACLITAXEL; PAZOPANIB; PENICILLAMINE; PRINOMASTAT; PROTEIN FARNESYLTRANSFERASE INHIBITOR; REBIMASTAT; SOLIMASTAT; SQUALAMINE; TANOMASTAT; THALIDOMIDE; TUMOR ANTIGEN; UNINDEXED DRUG;

EID: 33646174504     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.01.016     Document Type: Review
Times cited : (42)

References (59)
  • 1
    • 0036782278 scopus 로고    scopus 로고
    • VEGF and the quest for tumour angiogenesis factors
    • Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2 (2002) 795-803
    • (2002) Nat Rev Cancer , vol.2 , pp. 795-803
    • Ferrara, N.1
  • 2
    • 85013312416 scopus 로고
    • Tumor angiogenesis: therapeutic implications
    • Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 285 (1971) 1182-1186
    • (1971) N Engl J Med , vol.285 , pp. 1182-1186
    • Folkman, J.1
  • 3
    • 0025141337 scopus 로고
    • What is the evidence that tumors are angiogenesis dependent?
    • Folkman J. What is the evidence that tumors are angiogenesis dependent?. J Natl Cancer Inst 82 (1990) 4-6
    • (1990) J Natl Cancer Inst , vol.82 , pp. 4-6
    • Folkman, J.1
  • 4
    • 0034648765 scopus 로고    scopus 로고
    • Angiogenesis in cancer and other diseases
    • Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
    • (2000) Nature , vol.407 , pp. 249-257
    • Carmeliet, P.1    Jain, R.K.2
  • 5
    • 0030498734 scopus 로고    scopus 로고
    • Angiogenesis and metastasis
    • Ellis L.M., and Fidler I.J. Angiogenesis and metastasis. Eur J Cancer 32A (1996) 2451-2460
    • (1996) Eur J Cancer , vol.32 A , pp. 2451-2460
    • Ellis, L.M.1    Fidler, I.J.2
  • 6
    • 0026027556 scopus 로고
    • Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation
    • Liotta L.A., Steeg P.S., and Stetler-Stevenson W.G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64 (1991) 327-336
    • (1991) Cell , vol.64 , pp. 327-336
    • Liotta, L.A.1    Steeg, P.S.2    Stetler-Stevenson, W.G.3
  • 7
    • 1542319129 scopus 로고    scopus 로고
    • Cancer without disease
    • Folkman J., and Kalluri R. Cancer without disease. Nature 427 (2004) 787
    • (2004) Nature , vol.427 , pp. 787
    • Folkman, J.1    Kalluri, R.2
  • 8
    • 0031469819 scopus 로고    scopus 로고
    • Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
    • Boehm T., Folkman J., Browder T., and O'Reilly M.S. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 390 (1997) 404-407
    • (1997) Nature , vol.390 , pp. 404-407
    • Boehm, T.1    Folkman, J.2    Browder, T.3    O'Reilly, M.S.4
  • 9
    • 0028153751 scopus 로고
    • Isolation and identification of fresh tumor-derived endothelial cells from a murine RIF-1 fibrosarcoma
    • Modzelewski R.A., Davies P., Watkins S.C., Auerbach R., Chang M.J., and Johnson C.S. Isolation and identification of fresh tumor-derived endothelial cells from a murine RIF-1 fibrosarcoma. Cancer Res 54 (1994) 336-339
    • (1994) Cancer Res , vol.54 , pp. 336-339
    • Modzelewski, R.A.1    Davies, P.2    Watkins, S.C.3    Auerbach, R.4    Chang, M.J.5    Johnson, C.S.6
  • 11
    • 17944370631 scopus 로고    scopus 로고
    • Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors
    • Shaheen R.M., Ahmad S.A., Liu W., Reinmuth N., Jung Y.D., Tseng W.W., et al. Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors. Br J Cancer 85 (2001) 584-589
    • (2001) Br J Cancer , vol.85 , pp. 584-589
    • Shaheen, R.M.1    Ahmad, S.A.2    Liu, W.3    Reinmuth, N.4    Jung, Y.D.5    Tseng, W.W.6
  • 12
    • 0036570220 scopus 로고    scopus 로고
    • Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability
    • Liao F., Doody J.F., Overholser J., Finnerty B., Bassi R., Wu Y., et al. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability. Cancer Res 62 (2002) 2567-2575
    • (2002) Cancer Res , vol.62 , pp. 2567-2575
    • Liao, F.1    Doody, J.F.2    Overholser, J.3    Finnerty, B.4    Bassi, R.5    Wu, Y.6
  • 13
    • 0032535999 scopus 로고    scopus 로고
    • Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model
    • Arap W., Pasqualini R., and Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279 (1998) 377-380
    • (1998) Science , vol.279 , pp. 377-380
    • Arap, W.1    Pasqualini, R.2    Ruoslahti, E.3
  • 14
    • 0034125929 scopus 로고    scopus 로고
    • Current status of antiangiogenic factors
    • Talks K.L., and Harris A.L. Current status of antiangiogenic factors. Br J Haematol 109 (2000) 477-489
    • (2000) Br J Haematol , vol.109 , pp. 477-489
    • Talks, K.L.1    Harris, A.L.2
  • 15
    • 0037106374 scopus 로고    scopus 로고
    • Mechanisms and future directions for angiogenesis-based cancer therapies
    • Scappaticci F.A. Mechanisms and future directions for angiogenesis-based cancer therapies. J Clin Oncol 20 (2002) 3906-3927
    • (2002) J Clin Oncol , vol.20 , pp. 3906-3927
    • Scappaticci, F.A.1
  • 16
    • 10344220521 scopus 로고    scopus 로고
    • Endogenous angiogenesis inhibitors
    • Folkman J. Endogenous angiogenesis inhibitors. APMIS 112 (2004) 496-507
    • (2004) APMIS , vol.112 , pp. 496-507
    • Folkman, J.1
  • 17
    • 13244291424 scopus 로고    scopus 로고
    • Angiogenesis inhibitors in the treatment of colorectal cancer
    • Iqbal S., and Lenz H.J. Angiogenesis inhibitors in the treatment of colorectal cancer. Semin Oncol 31 (2004) 10-16
    • (2004) Semin Oncol , vol.31 , pp. 10-16
    • Iqbal, S.1    Lenz, H.J.2
  • 18
    • 2442621619 scopus 로고    scopus 로고
    • Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
    • Ferrara N., Hillan K.J., Gerber H.P., and Novotny W. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 3 (2004) 391-400
    • (2004) Nat Rev Drug Discov , vol.3 , pp. 391-400
    • Ferrara, N.1    Hillan, K.J.2    Gerber, H.P.3    Novotny, W.4
  • 19
    • 0033782775 scopus 로고    scopus 로고
    • Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine
    • Wei Y.Q., Wang Q.R., Zhao X., Yang L., Tian L., Lu Y., et al. Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine. Nat Med 6 (2000) 1160-1166
    • (2000) Nat Med , vol.6 , pp. 1160-1166
    • Wei, Y.Q.1    Wang, Q.R.2    Zhao, X.3    Yang, L.4    Tian, L.5    Lu, Y.6
  • 20
    • 10744233056 scopus 로고    scopus 로고
    • Vaccination with autologous endothelium inhibits angiogenesis and metastasis of colon cancer through autoimmunity
    • Okaji Y., Tsuno N.H., Kitayama J., Saito S., Takahashi T., Kawai K., et al. Vaccination with autologous endothelium inhibits angiogenesis and metastasis of colon cancer through autoimmunity. Cancer Sci 95 (2004) 85-90
    • (2004) Cancer Sci , vol.95 , pp. 85-90
    • Okaji, Y.1    Tsuno, N.H.2    Kitayama, J.3    Saito, S.4    Takahashi, T.5    Kawai, K.6
  • 23
    • 0141996422 scopus 로고    scopus 로고
    • Vascular endothelial growth factor receptor-2: its unique signaling and specific ligand, VEGF-E
    • Shibuya M. Vascular endothelial growth factor receptor-2: its unique signaling and specific ligand, VEGF-E. Cancer Sci 94 (2003) 751-756
    • (2003) Cancer Sci , vol.94 , pp. 751-756
    • Shibuya, M.1
  • 24
    • 0041439704 scopus 로고    scopus 로고
    • Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2
    • Liu J.Y., Wei Y.Q., Yang L., Zhao X., Tian L., Hou J.M., et al. Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2. Blood 102 (2003) 1815-1823
    • (2003) Blood , vol.102 , pp. 1815-1823
    • Liu, J.Y.1    Wei, Y.Q.2    Yang, L.3    Zhao, X.4    Tian, L.5    Hou, J.M.6
  • 25
    • 23944490634 scopus 로고    scopus 로고
    • Combination of low-dose gemcitabine and recombinant quail vascular endothelial growth factor receptor-2 as a vaccine induces synergistic antitumor activities
    • Hou J.M., Liu J.Y., Yang L., Zhao X., Tian L., Ding Z.Y., et al. Combination of low-dose gemcitabine and recombinant quail vascular endothelial growth factor receptor-2 as a vaccine induces synergistic antitumor activities. Oncology 69 (2005) 81-87
    • (2005) Oncology , vol.69 , pp. 81-87
    • Hou, J.M.1    Liu, J.Y.2    Yang, L.3    Zhao, X.4    Tian, L.5    Ding, Z.Y.6
  • 26
    • 0037124333 scopus 로고    scopus 로고
    • Active immunization against the vascular endothelial growth factor receptor flk1 inhibits tumor angiogenesis and metastasis
    • Li Y., Wang M.N., Li H., King K.D., Bassi R., Sun H., et al. Active immunization against the vascular endothelial growth factor receptor flk1 inhibits tumor angiogenesis and metastasis. J Exp Med 195 (2002) 1575-1584
    • (2002) J Exp Med , vol.195 , pp. 1575-1584
    • Li, Y.1    Wang, M.N.2    Li, H.3    King, K.D.4    Bassi, R.5    Sun, H.6
  • 27
    • 0036913333 scopus 로고    scopus 로고
    • A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth
    • Niethammer A.G., Xiang R., Becker J.C., Wodrich H., Pertl U., Karsten G., et al. A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth. Nat Med 8 (2002) 1369-1375
    • (2002) Nat Med , vol.8 , pp. 1369-1375
    • Niethammer, A.G.1    Xiang, R.2    Becker, J.C.3    Wodrich, H.4    Pertl, U.5    Karsten, G.6
  • 28
    • 4043175386 scopus 로고    scopus 로고
    • A DNA vaccine against extracellular domains 1-3 of flk-1 and its immune preventive and therapeutic effects against H22 tumor cell in vivo
    • Lu F., Qin Z.Y., Yang W.B., Qi Y.X., and Li Y.M. A DNA vaccine against extracellular domains 1-3 of flk-1 and its immune preventive and therapeutic effects against H22 tumor cell in vivo. World J Gastroenterol 10 (2004) 2039-2044
    • (2004) World J Gastroenterol , vol.10 , pp. 2039-2044
    • Lu, F.1    Qin, Z.Y.2    Yang, W.B.3    Qi, Y.X.4    Li, Y.M.5
  • 29
    • 24744466525 scopus 로고    scopus 로고
    • T cell-mediated suppression of angiogenesis results in tumor protective immunity
    • Zhou H., Luo Y., Mizutani M., Mizutani N., Reisfeld R.A., and Xiang R. T cell-mediated suppression of angiogenesis results in tumor protective immunity. Blood 106 (2005) 2026-2032
    • (2005) Blood , vol.106 , pp. 2026-2032
    • Zhou, H.1    Luo, Y.2    Mizutani, M.3    Mizutani, N.4    Reisfeld, R.A.5    Xiang, R.6
  • 30
    • 19644378474 scopus 로고    scopus 로고
    • Rationale for antiangiogenic cancer therapy with vaccination using epitope peptides derived from human vascular endothelial growth factor receptor 2
    • Wada S., Tsunoda T., Baba T., Primus F.J., Kuwano H., Shibuya M., et al. Rationale for antiangiogenic cancer therapy with vaccination using epitope peptides derived from human vascular endothelial growth factor receptor 2. Cancer Res 65 (2005) 4939-4946
    • (2005) Cancer Res , vol.65 , pp. 4939-4946
    • Wada, S.1    Tsunoda, T.2    Baba, T.3    Primus, F.J.4    Kuwano, H.5    Shibuya, M.6
  • 31
    • 0035949593 scopus 로고    scopus 로고
    • Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen
    • Wei Y.Q., Huang M.J., Yang L., Zhao X., Tian L., Lu Y., et al. Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen. Proc Natl Acad Sci USA 98 (2001) 11545-11550
    • (2001) Proc Natl Acad Sci USA , vol.98 , pp. 11545-11550
    • Wei, Y.Q.1    Huang, M.J.2    Yang, L.3    Zhao, X.4    Tian, L.5    Lu, Y.6
  • 33
    • 0038498050 scopus 로고    scopus 로고
    • Inhibition of tumor growth with a vaccine based on xenogeneic homologous fibroblast growth factor receptor-1 in mice
    • He Q.M., Wei Y.Q., Tian L., Zhao X., Su J.M., Yang L., et al. Inhibition of tumor growth with a vaccine based on xenogeneic homologous fibroblast growth factor receptor-1 in mice. J Biol Chem 278 (2003) 21831-21836
    • (2003) J Biol Chem , vol.278 , pp. 21831-21836
    • He, Q.M.1    Wei, Y.Q.2    Tian, L.3    Zhao, X.4    Su, J.M.5    Yang, L.6
  • 34
    • 0034624074 scopus 로고    scopus 로고
    • Administration of a liposomal FGF-2 peptide vaccine leads to abrogation of FGF-2-mediated angiogenesis and tumor development
    • Plum S.M., Holaday J.W., Ruiz A., Madsen J.W., Fogler W.E., and Fortier A.H. Administration of a liposomal FGF-2 peptide vaccine leads to abrogation of FGF-2-mediated angiogenesis and tumor development. Vaccine 19 (2000) 1294-1303
    • (2000) Vaccine , vol.19 , pp. 1294-1303
    • Plum, S.M.1    Holaday, J.W.2    Ruiz, A.3    Madsen, J.W.4    Fogler, W.E.5    Fortier, A.H.6
  • 35
    • 1942487872 scopus 로고    scopus 로고
    • Generation of a specific immunological response to FGF-2 does not affect wound healing or reproduction
    • Plum S.M., Vu H.A., Mercer B., Fogler W.E., and Fortier A.H. Generation of a specific immunological response to FGF-2 does not affect wound healing or reproduction. Immunopharmacol Immunotoxicol 26 (2004) 29-41
    • (2004) Immunopharmacol Immunotoxicol , vol.26 , pp. 29-41
    • Plum, S.M.1    Vu, H.A.2    Mercer, B.3    Fogler, W.E.4    Fortier, A.H.5
  • 36
    • 13844250537 scopus 로고    scopus 로고
    • The epidermal growth factor receptor as a target for colorectal cancer therapy
    • Lockhart C., and Berlin J.D. The epidermal growth factor receptor as a target for colorectal cancer therapy. Semin Oncol 32 (2005) 52-60
    • (2005) Semin Oncol , vol.32 , pp. 52-60
    • Lockhart, C.1    Berlin, J.D.2
  • 37
    • 28044433677 scopus 로고    scopus 로고
    • Epidermal growth factor receptor and angiogenesis: opportunities for combined anticancer strategies
    • van Cruijsen H., Giaccone G., and Hoekman K. Epidermal growth factor receptor and angiogenesis: opportunities for combined anticancer strategies. Int J Cancer 117 (2005) 883-888
    • (2005) Int J Cancer , vol.117 , pp. 883-888
    • van Cruijsen, H.1    Giaccone, G.2    Hoekman, K.3
  • 38
    • 0036733591 scopus 로고    scopus 로고
    • Blockade of epidermal growth factor receptor signaling on tumor cells and tumor-associated endothelial cells for therapy of human carcinomas
    • Baker C.H., Kedar D., McCarty M.F., Tsan R., Weber K.L., Bucana C.D., et al. Blockade of epidermal growth factor receptor signaling on tumor cells and tumor-associated endothelial cells for therapy of human carcinomas. Am J Pathol 161 (2002) 929-938
    • (2002) Am J Pathol , vol.161 , pp. 929-938
    • Baker, C.H.1    Kedar, D.2    McCarty, M.F.3    Tsan, R.4    Weber, K.L.5    Bucana, C.D.6
  • 39
    • 20944443737 scopus 로고    scopus 로고
    • Active antitumor immunity elicited by vaccine based on recombinant form of epidermal growth factor receptor
    • Hu B., Wei Y., Tian L., Zhao X., Lu Y., Wu Y., et al. Active antitumor immunity elicited by vaccine based on recombinant form of epidermal growth factor receptor. J Immunother 28 (2005) 236-244
    • (2005) J Immunother , vol.28 , pp. 236-244
    • Hu, B.1    Wei, Y.2    Tian, L.3    Zhao, X.4    Lu, Y.5    Wu, Y.6
  • 40
    • 4344652820 scopus 로고    scopus 로고
    • Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer
    • Fonsatti E., and Maio M. Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer. J Transl Med 2 (2004) 18
    • (2004) J Transl Med , vol.2 , pp. 18
    • Fonsatti, E.1    Maio, M.2
  • 41
    • 4544236628 scopus 로고    scopus 로고
    • Active immunotherapy of tumors with a recombinant xenogeneic endoglin as a model antigen
    • Tan G.H., Wei Y.Q., Tian L., Zhao X., Yang L., Li J., et al. Active immunotherapy of tumors with a recombinant xenogeneic endoglin as a model antigen. Eur J Immunol 34 (2004) 2012-2021
    • (2004) Eur J Immunol , vol.34 , pp. 2012-2021
    • Tan, G.H.1    Wei, Y.Q.2    Tian, L.3    Zhao, X.4    Yang, L.5    Li, J.6
  • 42
    • 7044224626 scopus 로고    scopus 로고
    • Combination of low-dose cisplatin and recombinant xenogeneic endoglin as a vaccine induces synergistic antitumor activities
    • Tan G.H., Tian L., Wei Y.Q., Zhao X., Li J., Wu Y., et al. Combination of low-dose cisplatin and recombinant xenogeneic endoglin as a vaccine induces synergistic antitumor activities. Int J Cancer 112 (2004) 701-706
    • (2004) Int J Cancer , vol.112 , pp. 701-706
    • Tan, G.H.1    Tian, L.2    Wei, Y.Q.3    Zhao, X.4    Li, J.5    Wu, Y.6
  • 44
    • 2342464166 scopus 로고    scopus 로고
    • Identification of an HLA-A*0201 cytotoxic T lymphocyte epitope specific to the endothelial antigen Tie-2
    • Ramage J.M., Metheringham R., Conn A., Spendlove I., Moss R.S., Patton D.T., et al. Identification of an HLA-A*0201 cytotoxic T lymphocyte epitope specific to the endothelial antigen Tie-2. Int J Cancer 110 (2004) 245-250
    • (2004) Int J Cancer , vol.110 , pp. 245-250
    • Ramage, J.M.1    Metheringham, R.2    Conn, A.3    Spendlove, I.4    Moss, R.S.5    Patton, D.T.6
  • 46
    • 0036230027 scopus 로고    scopus 로고
    • Immunogene therapy of tumors with a vaccine based on the ligand-binding domain of chicken homologous integrin beta3
    • Lou Y.Y., Wei Y.Q., Yang L., Zhao X., Tian L., Lu Y., et al. Immunogene therapy of tumors with a vaccine based on the ligand-binding domain of chicken homologous integrin beta3. Immunol Invest 31 (2002) 51-69
    • (2002) Immunol Invest , vol.31 , pp. 51-69
    • Lou, Y.Y.1    Wei, Y.Q.2    Yang, L.3    Zhao, X.4    Tian, L.5    Lu, Y.6
  • 47
    • 0035678089 scopus 로고    scopus 로고
    • Identification of a novel membrane protein, HP59, with therapeutic potential as a target of tumor angiogenesis
    • Fu C., Bardhan S., Cetateanu N.D., Wamil B.D., Wang Y., Yan H.P., et al. Identification of a novel membrane protein, HP59, with therapeutic potential as a target of tumor angiogenesis. Clin Cancer Res 7 (2001) 4182-4194
    • (2001) Clin Cancer Res , vol.7 , pp. 4182-4194
    • Fu, C.1    Bardhan, S.2    Cetateanu, N.D.3    Wamil, B.D.4    Wang, Y.5    Yan, H.P.6
  • 48
    • 0034956272 scopus 로고    scopus 로고
    • The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis
    • John A., and Tuszynski G. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 7 (2001) 14-23
    • (2001) Pathol Oncol Res , vol.7 , pp. 14-23
    • John, A.1    Tuszynski, G.2
  • 49
    • 0037308585 scopus 로고    scopus 로고
    • Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-2
    • Su J.M., Wei Y.Q., Tian L., Zhao X., Yang L., He Q.M., et al. Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-2. Cancer Res 63 (2003) 600-607
    • (2003) Cancer Res , vol.63 , pp. 600-607
    • Su, J.M.1    Wei, Y.Q.2    Tian, L.3    Zhao, X.4    Yang, L.5    He, Q.M.6
  • 50
    • 0037267333 scopus 로고    scopus 로고
    • Validating survivin as a cancer therapeutic target
    • Altieri D.C. Validating survivin as a cancer therapeutic target. Nat Rev Cancer 3 (2003) 46-54
    • (2003) Nat Rev Cancer , vol.3 , pp. 46-54
    • Altieri, D.C.1
  • 51
    • 14944359615 scopus 로고    scopus 로고
    • Gene therapy for colon cancer by adeno-associated viral vector-mediated transfer of survivin Cys84Ala mutant
    • Tu S.P., Cui J.T., Liston P., Huajiang X., Xu R., Lin M.C., et al. Gene therapy for colon cancer by adeno-associated viral vector-mediated transfer of survivin Cys84Ala mutant. Gastroenterology 128 (2005) 361-375
    • (2005) Gastroenterology , vol.128 , pp. 361-375
    • Tu, S.P.1    Cui, J.T.2    Liston, P.3    Huajiang, X.4    Xu, R.5    Lin, M.C.6
  • 52
    • 12544259115 scopus 로고    scopus 로고
    • A DNA vaccine targeting survivin combines apoptosis with suppression of angiogenesis in lung tumor eradication
    • Xiang R., Mizutani N., Luo Y., Chiodoni C., Zhou H., Mizutani M., et al. A DNA vaccine targeting survivin combines apoptosis with suppression of angiogenesis in lung tumor eradication. Cancer Res 65 (2005) 553-561
    • (2005) Cancer Res , vol.65 , pp. 553-561
    • Xiang, R.1    Mizutani, N.2    Luo, Y.3    Chiodoni, C.4    Zhou, H.5    Mizutani, M.6
  • 53
    • 0030746260 scopus 로고    scopus 로고
    • Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen
    • Foon K.A., John W.J., Chakraborty M., Sherratt A., Garrison J., Flett M., et al. Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen. Clin Cancer Res 3 (1997) 1267-1276
    • (1997) Clin Cancer Res , vol.3 , pp. 1267-1276
    • Foon, K.A.1    John, W.J.2    Chakraborty, M.3    Sherratt, A.4    Garrison, J.5    Flett, M.6
  • 54
    • 20244383301 scopus 로고    scopus 로고
    • Phase I study of immunization with dendritic cells modified with fowlpox encoding carcinoembryonic antigen and costimulatory molecules
    • Morse M.A., Clay T.M., Hobeika A.C., Osada T., Khan S., Chui S., et al. Phase I study of immunization with dendritic cells modified with fowlpox encoding carcinoembryonic antigen and costimulatory molecules. Clin Cancer Res 11 (2005) 3017-3024
    • (2005) Clin Cancer Res , vol.11 , pp. 3017-3024
    • Morse, M.A.1    Clay, T.M.2    Hobeika, A.C.3    Osada, T.4    Khan, S.5    Chui, S.6
  • 55
    • 3142692559 scopus 로고    scopus 로고
    • Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma
    • Yu J.S., Liu G., Ying H., Yong W.H., Black K.L., and Wheeler C.J. Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma. Cancer Res 64 (2004) 4973-4979
    • (2004) Cancer Res , vol.64 , pp. 4973-4979
    • Yu, J.S.1    Liu, G.2    Ying, H.3    Yong, W.H.4    Black, K.L.5    Wheeler, C.J.6
  • 56
    • 0036342170 scopus 로고    scopus 로고
    • Immunological aspects of blood transfusions
    • Brand A. Immunological aspects of blood transfusions. Transpl Immunol 10 (2002) 183-190
    • (2002) Transpl Immunol , vol.10 , pp. 183-190
    • Brand, A.1
  • 57
    • 0026500945 scopus 로고
    • Effect of allogeneic blood transfusion on solid tumor growth and pulmonary metastases in mice
    • Shirwadkar S., Blajchman M.A., Frame B., and Singal D.P. Effect of allogeneic blood transfusion on solid tumor growth and pulmonary metastases in mice. J Cancer Res Clin Oncol 118 (1992) 176-180
    • (1992) J Cancer Res Clin Oncol , vol.118 , pp. 176-180
    • Shirwadkar, S.1    Blajchman, M.A.2    Frame, B.3    Singal, D.P.4
  • 58
    • 0028110311 scopus 로고
    • Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery
    • Heiss M.M., Mempel W., Delanoff C., Jauch K.W., Gabka C., Mempel M., et al. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 12 (1994) 1859-1867
    • (1994) J Clin Oncol , vol.12 , pp. 1859-1867
    • Heiss, M.M.1    Mempel, W.2    Delanoff, C.3    Jauch, K.W.4    Gabka, C.5    Mempel, M.6
  • 59
    • 13844312942 scopus 로고    scopus 로고
    • A novel method for isolation of endothelial cells and macrophages from murine tumors based on Ac-LDL uptake and CD16 expression
    • Okaji Y., Tsuno N.H., Kitayama J., Saito S., Takahashi T., Kawai K., et al. A novel method for isolation of endothelial cells and macrophages from murine tumors based on Ac-LDL uptake and CD16 expression. J Immunol Methods 295 (2004) 183-193
    • (2004) J Immunol Methods , vol.295 , pp. 183-193
    • Okaji, Y.1    Tsuno, N.H.2    Kitayama, J.3    Saito, S.4    Takahashi, T.5    Kawai, K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.